問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2024-02-21

陳彥如醫師
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2022-12-14 - 2026-01-01

Phase III

Active
A multi-center, randomized, double-blind, active-controlled, therapeutic confirmatory, phase III study to compare and evaluate the efficacy and safety of Epaminurad with Febuxostat in gout patients
  • Condition/Disease

    gout

  • Test Drug

    Epaminurad

Participate Sites
13Sites

Not yet recruiting1Sites

Recruiting12Sites